Increasing the serum IGF-1 levels (via clenbuterol treatment, a beta adrenergic agonist (Mellios et al., 2014)) and environmental enrichment (Kondo et al., 2016) resulted in anxiety behaviour returning to wildtype levels. This evidence concerns the gene IGF1 and Anxiety.